2022-Ra-653-Esgo The Impact of Histology, Prior Therapy, and Dmmr Status on Lenvatinib + Pembrolizumab Outcomes in Patients with Advanced Endometrial Cancer: A Subgroup Analysis of Study 309/Keynote-775

AuthID
P-00Y-VYM
20
Author(s)
Lorusso, D
·
Makker, V
·
Herraez, AC
·
Monk, BJ
·
Mackay, H
·
Santin, AD
·
Moore, R
·
Baron-Hay, S
·
Ray-Coquard, I
·
Shapira-Frommer, R
·
Ushijima, K
·
Yonemori, K
·
Kim, YM
·
Guerra Alia, EM
·
Sanli, UA
·
Huang, J
·
McKenzie, J
·
Barresi, G
·
Colombo, N
Document Type
Proceedings Paper
Year published
2022
Published
in Endometrial cancer
Indexing
Publication Identifiers
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.